JP
STJ

John Paulson’s St Jude Medical STJ Stock Holding History

John Paulson’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-94,500
Closed -$7.54M – 114
2016
Q3 		$7.54M Buy
94,500
+49,000
+108% +$3.96M 0.08% 63
2016
Q2 		$3.55M Buy
+45,500
New +$3.24M 0.04% 69

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

John Paulson's STJ Position: Q4 2016 in Review

John Paulson sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 94,500 shares — an estimated $7.54M sold.

John Paulson first reported a position in STJ in Q2 2016 and held it in 2 quarters. The position peaked at $7.54M in Q3 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • John Paulson reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • John Paulson sold 94,500 St Jude Medical shares in Q4 2016, an estimated $7.54M.
  • John Paulson first reported a position in St Jude Medical in Q2 2016 and held it in 2 quarters.
  • John Paulson's St Jude Medical position peaked at $7.54M in Q3 2016.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Paulson & Co's 13F filing for Q4 2016, filed 14 Feb 2017.